Related by context. All words. (Click for frequent words.) 73 Hepatotoxicity 72 Hematological 71 Prolongs Survival 71 INCB# [003] 70 Ischemic 70 relapsed MM 70 Dasatinib 70 metastatic malignant 70 Toxicities 70 endometrial hyperplasia 70 Adenomas 70 Cardiotoxicity 70 Thromboembolic 69 fosbretabulin 69 Oral Fingolimod 69 haematologic 69 Nonalcoholic Fatty Liver Disease 69 Atypical Hemolytic Uremic Syndrome 69 AA Amyloidosis 69 Virologic 69 Myelodysplastic Syndromes 69 Immunotherapeutic 69 Nilotinib 68 See CLINICAL PHARMACOLOGY 68 Chronic Lymphocytic Leukemia CLL 68 Anthracycline 68 Leukemias 68 hematologic parameters 68 Metastases 68 efalizumab 68 Malignancies 68 headache abdominal pain 68 SPRYCEL ® 68 FluCAM arm 68 Cutaneous T 68 CLINICAL PHARMACOLOGY 68 Microalbuminuria 68 Neulasta ® 68 dual endothelin receptor antagonist 68 neutropenia dehydration dyspnea 68 Juvenile Idiopathic Arthritis 68 papillary renal cell carcinoma 68 Soft Tissue Sarcoma 68 Severe Asthma 68 colorectal adenoma 68 recurrent glioblastoma multiforme 68 Patients Treated With 68 intravascular hemolysis 68 abacavir Ziagen 67 colorectal carcinoma 67 Pharmacologic 67 adalimumab Humira 67 Carcinomas 67 invasive candidiasis 67 nasopharyngitis headache 67 myelodysplastic myeloproliferative diseases 67 corticosteroid therapy 67 Known hypersensitivity 67 Hormone Refractory Prostate Cancer 67 Lupus Nephritis 67 polycythemia vera PV 67 renal toxicity 67 Myelodysplastic Syndrome 67 Bisphosphonate 67 Malignant Melanoma 67 B Cell Lymphoma 67 Allergic Rhinitis 67 Inflammatory Diseases 67 Neoplasms 67 Tyrosine Kinase Inhibitor 67 leiomyomas 67 CYT# potent vascular disrupting 67 Hypotension 67 Pharmacodynamic 67 receptor tyrosine kinase inhibitor 67 Preclinical Models 67 psoriatic arthritis PsA 67 Neutropenia 67 atypical Hemolytic Uremic Syndrome 67 dermatologic reactions 67 Estrogen Receptor 67 extrapyramidal symptoms 67 Hepatic 67 histological subtype 67 Renal Cell Cancer 67 kidney urologic 67 Castration Resistant Prostate Cancer 67 moderate hepatic impairment 67 AST ALT 67 Epidermal Growth Factor Receptor 67 Gastric Cancer 67 CYP#A# substrate 67 neutropaenia 67 Gastrointestinal GI 67 Hepatocellular Carcinoma 67 sunitinib Sutent 67 Hypercholesterolemia 67 cytomegalovirus infection 67 Solid Tumors 67 baseline LDH 67 Eculizumab 67 thalidomide Thalomid 67 clevidipine 67 Malignant Glioma 67 stage IIIB 66 Shows Efficacy 66 STRIDE PD 66 Lymphoid 66 hyperphenylalaninemia HPA due 66 Patients Receiving 66 Investigational Treatment 66 pharmacodynamic parameters 66 hematologic toxicity 66 gastric carcinoma 66 PAOD 66 Adjuvant Treatment 66 Chronic Myelogenous Leukemia 66 Adenoma Prevention 66 Antiangiogenic 66 Mycophenolate Mofetil 66 Protease Inhibitors 66 Velcade bortezomib 66 Phase 2b Clinical Trial 66 Anti Tumor 66 Autoimmune Diseases 66 desvenlafaxine succinate 66 Non Alcoholic Fatty 66 HBeAg negative 66 Fondaparinux 66 Cell Lymphoma 66 secondary hyperparathyroidism 66 Deforolimus 66 Pemetrexed 66 Complicated Skin 66 ovarian carcinoma 66 hematological parameters 66 Angioedema 66 Histologic 66 Relapsing Multiple Sclerosis 66 gastric adenocarcinoma 66 pulmonary metastases 66 Lubiprostone 66 cinacalcet 66 Oncologic 66 Relapsing Remitting Multiple Sclerosis 66 QTc prolongation 66 erlotinib Tarceva ® 66 Squamous Cell Carcinoma 66 Epratuzumab 66 Myelodysplastic Syndrome MDS 66 ACE Inhibitors 66 Hepatocellular Carcinoma HCC 66 R lenalidomide 66 Interferon Beta 66 nonmetastatic 66 Anti Tumor Activity 66 serum phosphate 66 leucopenia 66 urothelial carcinoma 66 K ras mutations 66 Telbivudine 66 Gleevec resistant 66 Demonstrates Efficacy 66 Clinical Trial Results 66 Severe Sepsis 66 affective psychosis 66 dopaminergic therapy 66 Chronic Renal Failure 66 APTIVUS r 66 Pancreatic 66 Chronic Sinusitis 66 Myocardial Ischemia 66 neutropenia thrombocytopenia 66 bullous 66 Improves Outcomes 66 Invasive Breast Cancer 66 MGd 66 Adjuvant Chemotherapy 66 primary hyperparathyroidism 66 hypomagnesemia 66 sorafenib Nexavar 66 Tumor Response 66 Nebulized 66 cytogenic 66 Metastatic Prostate Cancer 66 Ozarelix 66 thromboembolic disease 66 Pulmonary Arterial Hypertension 66 Hyperlipidemia 66 liver metastasis 66 Atherosclerotic 66 MDS MPD 66 Pivotal Phase III 66 Diffuse Large B 66 metastatic neuroendocrine tumors 66 HIV HCV coinfected 66 Dupuytren Disease 66 Platinol ® 66 anemia thrombocytopenia 66 Aflibercept 66 Respiratory Virus 66 vWD 66 completely resected 66 urothelial 66 p# biomarker 66 Generalized Anxiety Disorder 66 BARACLUDE ® 66 TNF Blockers 66 HER2 expression 66 EXJADE 65 hypercalcemia 65 Tigecycline 65 INVEGA ® 65 myeloproliferative diseases 65 Advanced Renal Cell 65 pyrexia mucositis sepsis febrile 65 R Saizen R 65 gastrointestinal perforation 65 Investigational Drug 65 Peripheral Arterial 65 Bioequivalence 65 Progenitor Cells 65 Basal Cell 65 severe hypersensitivity reactions 65 Renal Cell Carcinoma RCC 65 β blockers 65 hypophosphatemia 65 follicular lymphoma FL 65 Cognitive Impairment 65 Benign Prostatic Hyperplasia 65 Postmarketing 65 hematological toxicities 65 Daptomycin 65 thrombocytopenia neutropenia 65 cMET 65 CIMZIA TM certolizumab pegol 65 Thrombocytopenia 65 colorectal liver metastases 65 sitaxsentan 65 Adenoma 65 antiproliferative effects 65 chronic eosinophilic leukemia 65 Fulvestrant 65 GW# [003] 65 Erythropoietic therapies may 65 breast endometrial 65 Exacerbations 65 Follicular Lymphoma 65 receiving XGEVA 65 Chronic Heart Failure 65 epithelial tumors 65 oral antidiabetic medication 65 Chronic Myeloid Leukemia 65 quetiapine Seroquel 65 rituximab Rituxan 65 Prostatic 65 Renal Cell Carcinoma 65 Advanced Melanoma 65 Naive Patients 65 Prophylactic Treatment 65 ACTEMRA TM 65 Chronic HCV 65 invasive aspergillosis 65 Sustained Efficacy 65 Renal Impairment 65 transaminase elevations 65 myopathy rhabdomyolysis 65 proliferative diabetic retinopathy 65 citalopram Celexa 65 atypical hemolytic uremic syndrome 65 chills fever headache 65 lenalidomide dexamethasone 65 Immune Mediated 65 Newly Diagnosed Multiple Myeloma 65 ATACAND 65 thyrotoxicosis 65 Lung Injury 65 Demonstrate Significant 65 Rheumatoid Arthritis RA 65 essential thrombocythemia ET 65 morphometric vertebral fractures 65 basal cell carcinoma BCC 65 Antitumor 65 dasatinib Sprycel 65 Endometrial 65 lichen planus 65 DOXIL 65 docetaxel Taxotere ® 65 nephrotoxicity 65 MALT lymphoma 65 ORENCIA R 65 Tiotropium 65 Metastatic Colorectal Cancer 65 Overactive Bladder 65 ALT flares 65 gastrointestinal toxicities 65 gastrointestinal stromal tumors GISTs 65 subependymal giant cell 65 benign prostatic hypertrophy BPH 65 Clinical Efficacy 65 Bosutinib 65 cytopenias 65 Myelofibrosis 65 Hsp# Inhibitor 65 liposomal amphotericin B 65 ritonavir boosted 65 Thiazolidinediones 65 Pancreas Cancer 65 Warfarin Coumadin 65 Monotherapy 65 erythropoietic 65 Natalizumab 65 gonococcal 65 Immunosuppressive 65 galiximab 65 mapatumumab 65 Idiopathic Pulmonary Fibrosis 65 Degarelix 65 STELARA TM 65 TTR amyloidosis 65 Lymphocytic 65 Aurora Kinase 65 Mutational 65 Pegylated Interferon 65 Bronchiectasis 65 acute humoral rejection 65 Rheumatoid Arthritis Patients 65 Antiplatelet 65 Novel Inhibitor 65 Bucindolol 65 Vidofludimus 65 tumor necrosis 65 Diabetic Nephropathy 65 Clinical Outcome 65 Placebo Controlled Study 65 Metabolic Disease 65 SSc 65 Enzastaurin 65 Inflammatory Markers 65 Asymptomatic 65 Tolvaptan 65 Cytogenetic 65 Randomized Study 65 Catheter Associated 65 trastuzumab Herceptin ® 65 isoproterenol 65 lymphoma subtypes 65 Thrombotic 65 Unstable Angina 65 Chemotherapy induced 65 metastatic colorectal 65 candesartan cilexetil 65 Systemic Sclerosis 65 Placebo Controlled Trial 65 recurrent glioma 65 voriconazole 65 juvenile idiopathic arthritis 65 flutamide 65 Hemorrhagic Stroke 65 NAVISTAR R 65 selective modulator 65 Skeletal Muscle 65 BZA CE 65 metastatic gastric 65 CIMZIA ™ 65 alkylating agent 65 aminotransferase 65 gastrointestinal stromal tumors GIST 65 aripiprazole Abilify 65 vidofludimus 65 Meets Primary Endpoint 65 TNFalpha 64 Study Evaluating 64 mTOR inhibitors 64 Vaprisol 64 pretransplant 64 Adefovir 64 zoledronic acid Zometa 64 Hypocalcemia 64 squamous cell lung cancer 64 Postmenopausal 64 ADPKD 64 Treatment Outcome 64 Renal Artery 64 Prospective Randomized 64 Pharmacokinetics PK 64 hepatic enzyme 64 Ribavirin causes 64 Renal Function 64 Pegylated Liposomal Doxorubicin 64 posaconazole 64 deep venous thromboses 64 riociguat 64 TMP SMX 64 Antitumor Activity 64 induce orthostatic hypotension 64 Candida infection 64 tigecycline 64 Non Responders 64 Diabetic Foot Ulcer 64 metastatic GIST 64 Pseudomonas aeruginosa infections 64 histologic subtype 64 Pharmacokinetic 64 Novel Therapeutic 64 oral FTY# 64 Doxil ® 64 prolonged QT interval 64 Atopic Dermatitis 64 chemotherapy induced neutropenia 64 gefitinib Iressa 64 Phase Ib Clinical Trial 64 Darinaparsin 64 demonstrated antitumor activity 64 Immunologic 64 AZT zidovudine Retrovir 64 Treating Chronic 64 Renal Cancer 64 Vidaza ® 64 CIN3 64 tipranavir ritonavir 64 hypocalcaemia 64 NOMID 64 Refractory Hodgkin Lymphoma 64 adenomatous 64 concomitant medications 64 Interferon Alfa 64 Ziprasidone 64 Chronic Lymphocytic Leukemia 64 inducible nitric oxide synthase 64 hyperprolactinemia 64 Golimumab 64 Chronic Hepatitis B 64 nicardipine 64 Clinical Relevance 64 lymphomas leukemias 64 receiving VELCADE 64 FUSILEV enhances 64 antiphospholipid syndrome 64 Retreatment 64 exploratory endpoints 64 Genetic Variation 64 NMIBC 64 parkinsonian symptoms 64 familial amyloidotic polyneuropathy FAP 64 Candesartan 64 hepatic cirrhosis 64 LYSTEDA 64 Immune Responses 64 Etanercept 64 Pulmonary Hypertension 64 venous thromboembolic disease 64 Kepivance 64 Myelosuppression 64 nonhematologic adverse reactions 64 unresectable HCC 64 tumor lysis syndrome 64 cutaneous squamous cell carcinoma 64 Adverse Event 64 adrenocortical cancer 64 paricalcitol 64 rFVIIa 64 Denufosol 64 Pioglitazone 64 Autoimmune Disorders 64 advanced adenoma 64 headache nasopharyngitis 64 erythema nodosum 64 ORENCIA ® 64 interleukin IL -# 64 Pegloticase 64 CP CPPS 64 vWF 64 urothelial cancer 64 trimethoprim sulfamethoxazole 64 Thalomid ® 64 cardiac repolarization 64 hepatotoxicity 64 Dendritic Cells 64 Metastatic Melanoma 64 Non inferiority 64 Xelox 64 tumor histology 64 Glucocorticoids 64 cardiac conduction 64 Shows Promise Against 64 AVAPRO 64 Arrhythmias 64 Parathyroid Hormone 64 Inflammatory Disease 64 EGFR HER2 64 taxane resistant 64 essential thrombocythemia 64 Schizophrenia Treatment 64 Fibrates 64 sunitinib Sutent ® 64 Ischaemic 64 Progressive Multifocal Leukoencephalopathy 64 G CSFs 64 Fracture Risk 64 Phase 2b Study 64 advanced adenomas 64 Rheumatoid 64 HIF PHI 64 Cardiovascular Outcomes 64 lymphocytosis 64 Peginterferon Alfa 2a 64 gadobutrol 64 pT2 64 alpha 2a 64 HER2 overexpression 64 myeloperoxidase 64 Initiates Clinical Trial 64 ARCALYST ® 64 Systemic Lupus Erythematosus SLE 64 Alequel 64 Safinamide 64 Omacetaxine 64 Vertebral Fractures 64 hematologic adverse 64 hepatic insufficiency 64 Subtypes 64 Patient Outcomes 64 Chronic Hepatitis C 64 idiopathic thrombocytopenic purpura 64 Novel Treatments 64 neutropenic patients 64 BEXXAR Therapeutic Regimen 64 FOLPI 64 Immunomodulatory 64 immunomodulatory therapy 64 fallopian tube cancers 64 hyperhomocysteinemia 64 MAGE A3 ASCI 64 Dyslipidemia 64 complement inhibitor eculizumab 64 plasma pharmacokinetics 64 Cervical Dysplasia 64 pancytopenia 64 Sipuleucel T 64 macroalbuminuria 64 unresectable tumors 64 evaluating tivozanib 64 VAPRISOL 64 arterial thromboembolic 64 haematological 64 EGFR TKI 64 therapeutic regimens 64 Fungal Infections 64 anogenital warts 64 aspartate aminotransferase AST 64 Pemphigus 64 Metastatic Renal Cell Carcinoma 64 headache nausea diarrhea 64 alfuzosin 64 cholecystitis 64 Aortic Stenosis 64 Dacogen decitabine 64 decompensated liver disease 64 Autoimmune Disease 64 Tavocept 64 liver transaminases 64 Cholinesterase Inhibitors 64 Tacrolimus 64 dasatinib Sprycel ® 64 aromatase inhibitor therapy 64 Polymorphisms 64 Esophageal 64 Orthostatic Hypotension 64 Romiplostim 64 grade cervical intraepithelial 64 G6PD deficiency 64 Pegylated 64 Immunohistochemistry 64 Subgroup analysis 64 Mouse Models 64 infliximab Remicade 64 proctitis 64 MYLOTARG 64 renal insufficiency 64 IDH1 mutation 64 hypocalcemia 64 Bortezomib 64 Septic Shock 64 Autologous Stem Cell Transplantation 64 immunomodulatory agents 64 Acute Renal Failure 64 paroxetine Paxil 64 Clusterin 64 transaminase levels 64 diabetic kidney 64 refractory gout 64 ara C 64 Paraplatin ® 64 Oral Formulation 64 urticaria hives 64 Hyperparathyroidism 64 hepatic failure 64 neoadjuvant treatment 64 Antiviral Activity 64 Adjunctive 64 Acute Stroke 64 Phase 2a Clinical Trial 64 mecamylamine 63 Myelodysplastic syndromes MDS 63 graft occlusion 63 Venous Thromboembolism 63 Mg Uk 63 CTAP# Capsules 63 cystic fibrosis chronic pancreatitis 63 Lamotrigine 63 Teriflunomide 63 acute GVHD 63 eosinophilic asthma 63 Neoadjuvant Chemotherapy 63 Critical Limb Ischemia CLI 63 palifermin 63 Fabry Disease 63 Double Blind Randomized 63 included neutropenia anemia 63 CIN2 + 63 Patency 63 Left Ventricular 63 imatinib Gleevec ® 63 Periodontitis 63 lymphoid malignancies 63 hepatorenal syndrome 63 Leydig cell 63 Polyneuropathy 63 follicular lymphomas 63 moderate renal impairment 63 TNF Tumor Necrosis Factor 63 pulmonary metastasis 63 gastroduodenal 63 Posaconazole 63 Kinase Inhibitors 63 primidone 63 Corticosteroid 63 Raptiva R 63 SUTENT ® 63 seropositive patients 63 hepatic fibrosis 63 HeFH 63 adriamycin 63 included exfoliative dermatitis 63 Zorbtive TM 63 hypoperfusion 63 hematological adverse 63 Respiratory Syncytial Virus 63 prospectively stratified 63 lenalidomide Revlimid R 63 NSAID induced 63 intravesical therapy 63 Hormone Receptor Positive 63 fluvastatin 63 superficial bladder cancer 63 neurological manifestations 63 Potent Anti 63 platelet dysfunction 63 metachronous 63 allograft rejection 63 androgen ablation 63 treat benign prostatic 63 tocilizumab 63 Urinary tract 63 peripheral sensory neuropathy 63 INSPIRE Trial Phase III 63 Relapsed Refractory 63 Showed Significant 63 alpha1 antitrypsin deficiency 63 Diastolic Heart Failure 63 tumoral 63 CIPN 63 Neovascular Age Related Macular 63 pheochromocytoma 63 Bosentan 63 thromboembolic complications 63 hypereosinophilic syndrome 63 dopamine D2 63 Achieves Primary Endpoint 63 refractory prostate cancer 63 Decitabine 63 Vidaza azacitidine 63 prospective multicenter study 63 hepatic enzymes 63 Iron Overload 63 elevated ALT 63 gallium nitrate 63 angioneurotic edema 63 Glufosfamide 63 mycosis fungoides 63 cytopenia 63 genotypic resistance 63 Esophagitis 63 hepatic liver 63 hepatic function 63 hepatic dysfunction 63 tardive dyskinesia TD 63 canakinumab 63 T1DM 63 bone marrow suppression 63 Aliskiren 63 neoplasias 63 recurrent metastatic 63 Excretion 63 hematopoietic cancers 63 Antipsychotic 63 hypervascular tumors 63 GLIADEL R Wafer 63 myelofibrosis polycythemia vera 63 Peginterferon alfa 2b 63 Pooled Analysis 63 miconazole Lauriad ® 63 Infected Patients 63 Diabetic Neuropathy 63 Secondary Hyperparathyroidism 63 systemic lupus erythematosus SLE 63 overactive bladder syndrome 63 Postmenopausal Women 63 mucosal inflammation 63 Metastatic 63 Localized Prostate Cancer 63 Keratitis 63 leukemia AML 63 Cytotoxic 63 VaD 63 Dual Antiplatelet Therapy 63 hyperalgesia 63 sJIA 63 systemic fungal infections 63 methicillin susceptible Staphylococcus aureus 63 Targeted Therapy 63 Infusion Reactions Severe 63 Dose Ranging Study 63 ® lenalidomide 63 Paroxysmal Nocturnal Hemoglobinuria PNH 63 dasatinib 63 Combination REOLYSIN R 63 transthyretin amyloidosis 63 CTAP# 63 lipid lowering agents 63 Saforis 63 Improved Survival 63 oesophagitis 63 Enzyme Replacement Therapy 63 CYP#D# inhibitor 63 Adalimumab 63 renal allograft 63 somatostatin analogs 63 cytotoxic effects 63 alanine aminotransferase 63 biliary tract cancer 63 ductal carcinomas 63 hypertrophic scars 63 medically inoperable 63 hyperparathyroidism 63 receptor inhibitor 63 Pivotal Study 63 arterial calcification 63 Acute Ischemic Stroke 63 gastric cardia 63 hemorrhagic cystitis 63 Ascites 63 Bronchopulmonary Dysplasia 63 Efficacy Trial 63 candidemia 63 Minimally Invasive Treatment 63 Cutaneous 63 Left Ventricular Dysfunction 63 hypothalamic pituitary adrenal axis 63 overt hypothyroidism 63 ST Segment Elevation 63 corticosteroid induced 63 PEG IFN 63 Autoantibodies 63 Liver Injury 63 OHR/AVR# 63 Acute Bacterial Sinusitis ABS 63 cholelithiasis 63 Papillary 63 hA# 63 Treated Patients 63 PsA 63 nausea vomiting headache 63 cytogenetic responses 63 tamoxifen Nolvadex ® 63 5 HT6 receptor 63 Gastrointestinal Stromal Tumors 63 differentiated thyroid 63 venlafaxine Effexor 63 diabetic gastroparesis 63 Liver Failure 63 CHARM Added 63 HER2 Positive Breast Cancer 63 ergot alkaloids 63 endometrial carcinoma 63 elevated transaminases 63 Breast Cancers 63 Cholangiocarcinoma 63 Serious adverse reactions 63 TORISEL 63 Traficet EN 63 metaplasia 63 hemorrhagic complications 63 lymphopenia 63 TNF blocker therapy 63 Etiology 63 cranial irradiation 63 Hypertrophy 63 ß blockers 63 immunotoxicity 63 bronchial hyperresponsiveness 63 Successfully Treated 63 Archexin 63 Survival Benefit 63 mcg QD 63 Glioblastoma Multiforme 63 chronic GVHD 63 Flu Cy 63 Ocrelizumab 63 onset diabetes mellitus 63 Breast Cancer Recurrence 63 Inhibitory 63 fatal anaphylactic 63 dexamethasone Decadron 63 myoclonus 63 JAK Inhibitor 63 FOLFOX6 63 Orally administered 63 prokinetic agent 63 carotid stenosis 63 GnRH agonists 63 immunosuppressive therapies 63 Kinase Inhibitor 63 Ovarian Cancers 63 CLL SLL 63 Pafuramidine 63 severe oral mucositis 63 bortezomib Velcade 63 tumor xenograft models 63 ACTOS ® 63 pegylated liposomal doxorubicin 63 Faropenem 63 anterior uveitis 63 Neck Cancers 63 Shows Promising 63 See WARNINGS 63 denileukin diftitox 63 colorectal adenocarcinoma 63 INTEGRILIN R 63 pancreatic adenocarcinoma 63 erosive gastritis 63 severe renal impairment 63 Gram Positive 63 mTOR mammalian target 63 vitamin B# folic acid 63 Oral Calcitonin 63 antiemetics 63 gastrointestinal motility 63 pancreatic prostate 63 Ranolazine 63 clinicopathological 63 IL# PE#QQR 63 post herpetic 63 caspofungin 63 Adjuvant Therapy 63 mycophenolate mofetil 63 Aneurysm Repair 63 symptomatic intracranial 63 Virological 63 Pediatric Patients 63 estramustine 63 oxycodone CR 63 RNAi Therapeutic 63 Comorbidities 63 Meta Analysis 63 keloid scarring 63 Navelbine 63 leukemia CLL 63 Coronary Artery Bypass Graft 63 imipramine Tofranil 63 TO AVOID PREGNANCY WHILE 63 Knee Osteoarthritis 63 bronchoalveolar lavage 63 Phase 2b Trial 63 5 Fluorouracil 63 Temsirolimus 63 relapsed ALL 63 Novel Oral 63 serum calcium levels 63 depsipeptide 63 erlotinib Tarceva 63 Neurogenic 63 Tyrosine Kinase Inhibitors 63 Neoadjuvant 63 Demonstrates Positive 63 Th2 cytokines 63 SNT MC# 63 BYSTOLIC 63 Nymox NX 63 Serious Adverse Events 63 Ventricular Tachycardia 63 Reduces Mortality 63 AGILECT R 63 WARNINGS Myopathy Rhabdomyolysis 63 plasma lipid 63 urolithiasis 63 Aspergillosis 63 mucinous 63 elotuzumab 63 incidence ≥ 63 Renal dysfunction 63 coinfected patients 63 carcinoid 63 antiangiogenic therapy 63 malignant pleural mesothelioma 63 node metastases 63 imatinib resistant 63 neuroendocrine cancers 63 GAMMAGARD 63 Elagolix 63 Teriparatide 63 oral prodrug 63 Androgen 63 Fludara ® 63 Proteinuria 63 Actinic Keratosis 63 PROCRIT ® 63 Mitomycin C 63 Serious Infections 63 HMG CoA reductase inhibitors 63 J. Clin 63 inhibitor RG# 63 Femara letrozole 63 pharmacokinetic interactions 63 PHPT 63 airway hyperresponsiveness 63 HSCT 63 mild hepatic impairment 63 LymphoStat B belimumab 62 triiodothyronine 62 novel VDA molecule 62 etanercept Enbrel 62 laboratory abnormalities 62 Nonspecific 62 Thrombus 62 null responder 62 neutropenia febrile neutropenia 62 SYN# 62 pulmonary exacerbations 62 Chronic Prostatitis 62 Hemodialysis Patients 62 antiretroviral naïve 62 leukotriene receptor antagonist 62 Previously Treated 62 ankylosing spondylitis AS 62 Irritable Bowel 62 Renal Anemia 62 Valsartan 62 renal cell carcinomas 62 Antihypertensive 62 MYCAMINE 62 Lymphomas 62 catheter occlusion 62 Iron Deficiency 62 osteosarcomas 62 Invasive Fungal Infections 62 Uterine Cancer 62 Phase IIb Clinical Trial 62 Personalized Immunotherapy 62 Lenalidomide 62 myomas 62 fibrin deposition 62 prostate cancer CaP 62 Cyclooxygenase 2 62 leukemia multiple myeloma 62 Respiratory Symptoms 62 Vasculitis 62 idiopathic Parkinson disease 62 Randomized Double blind 62 Anticoagulants 62 granulomatous 62 Breast Density 62 Entereg R 62 Antifungal 62 Allogeneic 62 Endometrial Cancer 62 Sapacitabine 62 elevated LDH 62 Febrile neutropenia 62 artery stenosis 62 opioid induced 62 haematological malignancies 62 Lipodystrophy 62 Carotid Endarterectomy 62 Stent thrombosis 62 bronchoalveolar lavage BAL 62 Myeloid 62 imatinib Gleevec